![](/img/cover-not-exists.png)
P-163 * Is KRAS status prognostic or predictive for anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer?
Satake, H., Tsuji, A., Imai, Y., Kotake, T., Okita, Y., Hatachi, Y.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.163
Date:
June, 2015
File:
PDF, 30 KB
english, 2015